Search - tctmd.com

Displaying 1 - 20 of 613

Sort: Relevancy | Date

Routine Protamine Reduces Minor Bleeding Compared With Selective Use: POPular ACE TAVI

News Conference News ESC 2026

Routine Protamine Reduces Minor Bleeding Compared With Selective Use: POPular ACE TAVI

Yael L. Maxwell

September 03, 2026

DOAC Prescribing for Primary and Secondary Prevention: ACC Offers Advice

News Daily News

DOAC Prescribing for Primary and Secondary Prevention: ACC Offers Advice

July 14, 2026

SAFER-TAVI: Radial Eases Secondary Access Site Problems

News Conference News NY Valves 2026

SAFER-TAVI: Radial Eases Secondary Access Site Problems

July 06, 2026

Presentation NY Valves 2026

Unfractionated Heparin Timing in Transseptal Puncture–Requiring Procedures: A Single‑Center Study

Presenter: Mohammed Hussein

June 25, 2026

STORM-PE: Mechanical Thrombectomy Boosts Walking and Daily Living Gains

News Conference News SIR 2026

STORM-PE: Mechanical Thrombectomy Boosts Walking and Daily Living Gains

April 20, 2026

HI-PEITHO: Catheter-Directed Therapy Bests Anticoagulation in Intermediate-Risk PE

News Conference News ACC 2026

HI-PEITHO: Catheter-Directed Therapy Bests Anticoagulation in Intermediate-Risk PE

March 28, 2026

Presentation THT 2026

Perioperative Management and Outcomes of Heparin-Induced Thrombocytopenia in Patients Undergoing HeartMate 3 Left Ventricular Assist Device Implantation: A Case Series

Presenter: Vaidehi Mendpara

March 02, 2026

SCAD-Related MI Not Just the Domain of Young Women: Serbian Registry

News Conference News EAPCI 2026

SCAD-Related MI Not Just the Domain of Young Women: Serbian Registry

February 27, 2026

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

News Conference News AHA 2025

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

Michael O'Riordan

November 11, 2025

ESC Guidelines Update Clarifies Pregnancy Risks and Choices in Women With CVD

News Conference News ESC 2025

ESC Guidelines Update Clarifies Pregnancy Risks and Choices in Women With CVD

September 09, 2025

No Benefit of Sentinel Device During TAVI: Updated Meta-analysis

News Conference News NY Valves 2025

No Benefit of Sentinel Device During TAVI: Updated Meta-analysis

July 04, 2025

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

News Daily News

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

March 06, 2025

Medical Management (Heparin/ Lytics)

Presentation THT 2025

Medical Management (Heparin/ Lytics)

Presenter: Gregory Piazza

February 12, 2025

Two Trials Boost Intra-arterial Lytics After Stroke Thrombectomy

News Conference News ISC 2025

Two Trials Boost Intra-arterial Lytics After Stroke Thrombectomy

February 11, 2025

TCT 583: Influence of Heparin-Induced Thrombocytopenia on In-Hospital Outcomes in Patients With Left Ventricular Assist Devices (LVAD): A Decade-Long Study

Presentation TCT 2024

TCT 583: Influence of Heparin-Induced Thrombocytopenia on In-Hospital Outcomes in Patients With Left Ventricular Assist Devices (LVAD): A Decade-Long Study

Presenter: Neethi Dasu

October 30, 2024

In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI

News Conference News TCT 2024

In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI

Yael L. Maxwell

October 29, 2024

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

News Conference News TCT 2024

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

October 29, 2024

TCT 235: Efficacy and Safety of Bivalirudin and Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients Who Underwent Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis

Presentation TCT 2024

TCT 235: Efficacy and Safety of Bivalirudin and Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients Who Underwent Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis

Presenter: Hamza Naveed

October 28, 2024

TCT 934: Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial

Presentation TCT 2024

TCT 934: Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial

Presenter: Jing Chen

October 28, 2024

Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial

Presentation TCT 2024

Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial

Presenter: Jing Chen

October 28, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.